RT Journal Article
SR Electronic
T1 Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003790
DO 10.1136/jitc-2021-003790
VO 9
IS 12
A1 Yang, Yunpeng
A1 Zhou, Ting
A1 Chen, Xiaozhong
A1 Li, Jingao
A1 Pan, Jianji
A1 He, Xiaohui
A1 Lin, Lizhu
A1 Shi, Ying-rui
A1 Feng, Weineng
A1 Xiong, Jianping
A1 Yang, Kunyu
A1 Yu, Qitao
A1 Zhang, Qunling
A1 Hu, Desheng
A1 Sun, Yan
A1 Hu, Guangyuan
A1 Li, Ping
A1 Shen, Liangfang
A1 Lin, Qin
A1 Zhang, Ben
A1 Qu, Xiao
A1 Zou, Jianjun
A1 Zhang, Li
A1 Fang, Wenfeng
A1 Zhao, Yuanyuan
YR 2021
UL http://jitc.bmj.com/content/9/12/e003790.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.